Sign Out
Do not use BROMESEP in patients with hypersensitivity to Brompheniramine maleate and/or Phenylephrine HCl and/or Glyceryl guaiacolate (for expectorant only) or any components of the formulation.
Because BROMESEP contains Phenylephrine HCl in the formulation, use this product with or within 14 days of monoamine oxidase inhibitor (MAOI) is contraindicated.
Because BROMESEP contains Brompheniramine in the formulation, therefore this product is contraindicated in patients with asthmatic attacks.
Continue with Google